PureTech Health (PRTC) Cash & Current Investments (2019 - 2024)
PureTech Health (PRTC) has disclosed Cash & Current Investments for 6 consecutive years, with $280.6 million as the latest value for Q4 2024.
- Quarterly Cash & Current Investments rose 46.87% to $280.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $280.6 million through Dec 2024, up 46.87% year-over-year, with the annual reading at $280.6 million for FY2024, 46.87% up from the prior year.
- Cash & Current Investments for Q4 2024 was $280.6 million at PureTech Health, up from $191.1 million in the prior quarter.
- The five-year high for Cash & Current Investments was $465.7 million in Q4 2021, with the low at $191.1 million in Q4 2023.
- Average Cash & Current Investments over 5 years is $338.3 million, with a median of $350.1 million recorded in 2022.
- The sharpest move saw Cash & Current Investments soared 148.62% in 2020, then tumbled 45.42% in 2023.
- Over 5 years, Cash & Current Investments stood at $403.9 million in 2020, then rose by 15.31% to $465.7 million in 2021, then dropped by 24.83% to $350.1 million in 2022, then crashed by 45.42% to $191.1 million in 2023, then surged by 46.87% to $280.6 million in 2024.
- According to Business Quant data, Cash & Current Investments over the past three periods came in at $280.6 million, $191.1 million, and $350.1 million for Q4 2024, Q4 2023, and Q4 2022 respectively.